Skip to main content

Portfolio, Licensing & Development Strategy 2

Our client sought to design a best-in-industry external innovation strategy for identifying, capturing and nurturing potentially disruptive innovation ahead of competitors.

Eradigm analysed the various models employed by industry peers, from incubators to crowdsourcing, and evaluated their relative success, to identify key research infrastructures and partnerships drivers which are being leveraged to enhance pre-clinical outcomes.